Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

4.81
Delayed Data
As of Feb 05
 -0.07 / -1.43%
Today’s Change
4.08
Today|||52-Week Range
15.01
-42.67%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Cadila Pharmaceuticals Ltd
Sale5/28/20152,000,000$8.70$17.4M-45.59%
Cadila Pharmaceuticals Ltd
Sale6/01/20151,500,000$8.80$13.2M-46.17%
Cadila Pharmaceuticals Ltd
Sale6/03/2015355,000$8.92$3.2M-46.02%
Cadila Pharmaceuticals Ltd
Sale6/10/2015297,375$9.01$2.7M-46.47%
Cadila Pharmaceuticals Ltd
Sale6/16/2015280,285$9.01$2.5M-46.44%
Cadila Pharmaceuticals Ltd
Sale6/08/2015206,175$8.93$1.8M-45.71%
Cadila Pharmaceuticals Ltd
Sale6/17/2015152,768$9.01$1.4M-47.32%
Cadila Pharmaceuticals Ltd
Sale6/02/201584,092$8.90$748.4K-45.89%
Cadila Pharmaceuticals Ltd
Sale6/04/201565,589$8.92$585.1K-45.09%
Glenn Gregory M
Senior Vice President-Research & Development
Sale12/16/201561,886$8.58$531.0K-45.15%
Page of 4